Heartflow's quarterly loss widened over the year-ago period, the healthcare company disclosed in its paperwork for a U.S.

Heartflow, an artificial intelligence-based medical device software developer, filed for an initial public offering in the ...

Check latest subscription status, grey market premium (GMP), allotment date, listing date, other key details here ...

Anthem Biosciences IPO allotment status online check can be done through the websites of BSE and NSE, along with the official ...

Seven & i Holdings Co. is drawing some skepticism about its plan to take its North American convenience stores business ...

Anthem Biosciences' shares will be listed today following a successful IPO. The Bengaluru-based company has set the issue price at ₹570, with an expected initial gain of 20-25%.

The transit software company, is finally taking the step into public markets with an IPO after abandoning the idea in 2021.

Heartflow has filed for an initial public offering. The company recorded sales of $125.8 million and a net loss of $96.4 million last year, according to a filing with the Securities and Exchange ...

WhiteFiber aims to raise $100M in a US IPO, tapping into AI infrastructure with Tier-3 data centers. Read the IPO analysis ...

By Kashish Tandon (Reuters) -Indian drugmaker Anthem Biosciences' [ANTH.NS] $395 million IPO was fully subscribed on the ...

The transit management software firm says its has filed a confidential filing with the SEC, potentially paving the way for a ...

The IPO Pulse actually peaked last October and has been slowing since then. But the downturn certainly accelerated in March and April as the stock market sold off, with the IPO Pulse falling to a ...